Elaine S. Ullian, chief executive officer of financially strapped Boston Medical Center, almost doubles her $1.3 million annual salary by sitting on the boards of three local companies that also do business with her hospital.
“What is she doing?” said John Gatti, a former government official turned waste and fraud watchdog. “Doesn’t she have enough to do, trying to run BMC with all the problems they have down there?”
Ullian’s lucrative corporate directorships - she also serves on each board’s executive compensation committee - raise questions about her professional commitments during a time of turbulence at the inner-city hospital, which just announced plans to eliminate 40 more jobs and close an intensive-care unit, Gatti said. ...
...
“Even if she isn’t making the purchasing decisions herself, it’s the appearance of impropriety that is wrong,” Gatti said.
Ullian, 61, has served as president and CEO of the 550-bed medical center since it was created in 1996.
In 2008, she was paid nearly $4.8 million from Boston Medical Center, including her $1.34 million salary and a one-time $3.5 million retirement bonus. She is slated to leave the hospital in January.
Last year, Ullian also received $337,480 in cash and stock to sit on Vertex Pharmaceuticals’ board of directors; $275,319 in cash and stock to serve on the board of Thermo Fisher Scientific Inc., a maker of medical instruments and laboratory supplies; and $304,698 to work on medical device maker Hologic Inc.’s board. ...
No comments:
Post a Comment